Once feared as a fatal diagnosis, HIV has transformed into a manageable chronic illness — all thanks to decades of medical breakthroughs.
In 1996, the average life expectancy for someone living with HIV was only 39 years. But by 2011, that number rose to 72 — nearly the same as the general population. This dramatic shift is largely due to widespread access to antiretroviral therapy (ART), a medication regimen that suppresses the virus to undetectable levels.
“You can have a normal lifespan and live just like someone who doesn’t have HIV,” says Dr. Ray Martins, a leading HIV specialist.
Today, people on ART not only live longer, but they also pose no risk of sexually transmitting the virus if it remains undetectable in their system — a powerful message summarized in the global health slogan “U=U” (Undetectable = Untransmittable).
But while science has delivered the tools, global access still lags. Experts are now calling on world leaders to ensure equitable treatment access for everyone, everywhere.
The battle isn’t over — but the outcome is no longer fatal.